Hoosiers Work for Health

"If a charity organization collected billions of dollars with little evidence that needy people benefited, regulators and the public would quickly demand answers.
Yet many large hospital systems participating in the federal 340B Drug Pricing Program are quietly doing just that—extracting billions in drug discounts with scarce oversight and no obligation to prove vulnerable patients benefit."

-Sally Pipes, President, CEO, Thomas W. Smith Fellow in Health Care Policy at the Pacific Research Institute

It’s Time For Congress To Get 340B Out Of Its Blind Spot When hospitals overcharge insurers for drugs they bought at deep 340B discounts, taxpayers, employers, and insured patients foot the bill.

Programs designed to support rural healthcare should benefit rural communities, not large, urban hospital systems exploiting loopholes.

A new study examining Medicare “dual classification” adds to growing concerns about transparency and accountability in programs like 340B. In a new piece from the Goshen News, Indiana State Grange President Jason Smith weighs in on what’s at stake for rural Hoosiers.

OP-ED: Protect rural health care for Hoosiers Rural Hoosiers have a simple way of life. My neighbors and fellow Grange members prefer it that way, but that doesn’t mean they should have to sacrifice access to quality

A federal judge's ruling on a North Dakota 340B law is shining a light on what has become one of healthcare’s biggest loopholes.

Hospitals acquire drugs at steep discounts and contract pharmacies profit while patients often see no savings at all.

The Wall Street Journal Editorial Board says policymakers can no longer ignore the problem.

The Great 340B Healthcare Grift A federal judge shows how this hospital ‘discount’ fleeces drug makers and patients.